Purpose To provide guidelines on antimicrobial prophylaxis for adult neutropenic oncology
outpatients and on selection and treatment as outpatients of those with fever and …

Purpose To provide an updated joint ASCO/Infectious Diseases Society of American (IDSA)
guideline on outpatient management of fever and neutropenia in patients with cancer …

This document updates and expands the initial Infectious Diseases Society of America
(IDSA) Fever and Neutropenia Guideline that was published in 1997 and first updated in …

Background Among patients with fever and neutropenia during cancer chemotherapy who
have a low risk of complications, oral administration of empirical broad-spectrum antibiotics …

BACKGROUND Hospitalization and treatment with broad‐spectrum intravenous antibiotics
is the standard care for patients with neutropenia and fever. This randomized clinical trial …

Purpose This double-blind, multicenter trial compared the efficacy and safety of a single
daily oral dose of moxifloxacin with oral combination therapy in low-risk febrile neutropenic …

Purpose To investigate the feasibility of withholding antibiotics and early discharge for
patients with chemotherapy-induced neutropenia and fever at low risk of bacterial infection …

Febrile neutropenia is one of the most serious complications in patients with haematological
malignancies and chemotherapy. A prompt identification of infection and empirical antibiotic …

BACKGROUND AND OBJECTIVES: It is now evident that patients experiencing febrile
neutropenia induced by chemotherapy do not constitute a homogeneous group. With …

Background. Hospitalization and intravenous (IV) broad‐spectrum antibiotics are the
standard of care for all febrile neutropenic patients with cancer. Recent work suggests that a …